OUTPATIENT CANCER PATIENTS: THE RELATIONSHIP BETWEEN INFORMATION OVERLOAD, SYMPTOM SEVERITY, AND EMPOWERMENT LEVEL

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Yalova

About this trial

Examining the relationship between information load, symptom severity, and empowerment level in outpatient cancer patients is of great importance for developing holistic care plans tailored to the individual needs of patients and for planning supportive interventions in oncology nursing.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

patients over 18 years of age receiving outpatient chemotherapy treatment

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Relationship Between Information Burden, Symptom Management, and Empowerment Levels in Patients Receiving Outpatient Chemotherapy

Evaluated via Cancer Patient Empowerment Scale (40 items, 5-point Likert). Subscales: Personal Power, Social Support, Healthcare, Community. Total score: 40-200. Higher scores indicate higher patient empowerment. Measured via Cancer Information Overload Scale (8 items, 4-point Likert). Total score: 8-32. Higher scores indicate higher cognitive burden. Evaluated via Memorial Symptom Assessment Scale (32 symptoms; GDI, Phys, Psych subscales). Total score (average): 0-4. Higher scores reflect higher symptom distress.

Time frame
01.07.2026-01.20.2026
2

Information burden, symptom severity, and reinforcement level in outpatient chemotherapy patients

Evaluated via Cancer Patient Empowerment Scale (40 items, 5-point Likert). Subscales: Personal Power, Social Support, Healthcare, Community. Total score: 40-200. Higher scores indicate higher patient empowerment. Measured via Cancer Information Overload Scale (8 items, 4-point Likert). Total score: 8-32. Higher scores indicate higher cognitive burden. Evaluated via Memorial Symptom Assessment Scale (32 symptoms; GDI, Phys, Psych subscales). Total score (average): 0-4. Higher scores reflect higher symptom distress.

Time frame
01.07.2026--01.10.2026

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: